Clinical Trial Update: ICARuS Post-operative Intraperitoneal Chemotherapy (EPIC) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) After Optimal Cytoreductive Surgery (CRS) for Neoplasms of the Appendix, Colon or Rectum With Isolated Peritoneal Metastasis [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing intraperitoneal chemotherapy (EPIC) and hyperthermic intraperitoneal chemotherapy (HIPEC) after optimal cytoreductive surgery for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Appendix Cancer
• Colorectal Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Appendix Cancer, Colorectal Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING